Annual Non Current Assets
$1.72 M
-$761.00 K-30.65%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual long term assets is $1.72 million, with the most recent change of -$761.00 thousand (-30.65%) on December 31, 2023.
- During the last 3 years, VYNE annual non current assets has fallen by -$4.76 million (-73.44%).
- VYNE annual non current assets is now -83.62% below its all-time high of $10.51 million, reached on December 31, 2016.
Performance
VYNE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$2.66 M
-$209.00 K-7.28%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly long term assets is $2.66 million, with the most recent change of -$209.00 thousand (-7.28%) on September 30, 2024.
- Over the past year, VYNE quarterly non current assets has dropped by -$209.00 thousand (-7.28%).
- VYNE quarterly non current assets is now -95.71% below its all-time high of $62.09 million, reached on March 31, 2020.
Performance
VYNE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
VYNE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.6% | -7.3% |
| 3 y3 years | -73.4% | +7.3% |
| 5 y5 years | +302.3% | +7.3% |
VYNE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.4% | at low | -31.0% | +83.3% |
| 5 y | 5-year | -73.4% | +104.5% | -95.7% | +216.3% |
| alltime | all time | -83.6% | -100.0% | -95.7% | >+9999.0% |
VYNE Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.66 M(-7.3%) |
| Jun 2024 | - | $2.87 M(+97.7%) |
| Mar 2024 | - | $1.45 M(-15.6%) |
| Dec 2023 | $95.96 M(+150.7%) | $1.72 M(-1.9%) |
| Sep 2023 | - | $1.76 M(-12.2%) |
| Jun 2023 | - | $2.00 M(-10.8%) |
| Mar 2023 | - | $2.24 M(-9.7%) |
| Dec 2022 | $38.27 M(-39.4%) | $2.48 M(-13.2%) |
| Sep 2022 | - | $2.86 M(-12.5%) |
| Jun 2022 | - | $3.27 M(-10.7%) |
| Mar 2022 | - | $3.67 M(-5.1%) |
| Dec 2021 | $63.19 M(-27.6%) | $3.86 M(-25.6%) |
| Sep 2021 | - | $5.19 M(-6.7%) |
| Jun 2021 | - | $5.56 M(-8.2%) |
| Mar 2021 | - | $6.05 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $87.26 M(+11.4%) | $6.48 M(-31.9%) |
| Sep 2020 | - | $9.52 M(-17.6%) |
| Jun 2020 | - | $11.55 M(-81.4%) |
| Mar 2020 | - | $62.09 M(+7274.3%) |
| Dec 2019 | $78.33 M(-43.9%) | $842.00 K(-73.2%) |
| Sep 2019 | - | $3.15 M(+150.4%) |
| Jun 2019 | - | $1.26 M(+21.3%) |
| Mar 2019 | - | $1.04 M(+142.1%) |
| Dec 2018 | $139.50 M(+118.4%) | $428.00 K(-12.7%) |
| Sep 2018 | - | $490.00 K(-95.4%) |
| Jun 2018 | - | $10.75 M(-48.4%) |
| Mar 2018 | - | $20.82 M(+592.6%) |
| Dec 2017 | $63.86 M(+102.5%) | $3.01 M(>+9900.0%) |
| Sep 2017 | - | $18.00 K(-99.8%) |
| Dec 2016 | $31.54 M(-28.1%) | $10.51 M |
| Dec 2015 | $43.88 M | - |
FAQ
- What is VYNE Therapeutics annual long term assets?
- What is the all time high annual non current assets for VYNE Therapeutics?
- What is VYNE Therapeutics annual non current assets year-on-year change?
- What is VYNE Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly non current assets year-on-year change?
What is VYNE Therapeutics annual long term assets?
The current annual non current assets of VYNE is $1.72 M
What is the all time high annual non current assets for VYNE Therapeutics?
VYNE Therapeutics all-time high annual long term assets is $10.51 M
What is VYNE Therapeutics annual non current assets year-on-year change?
Over the past year, VYNE annual long term assets has changed by -$761.00 K (-30.65%)
What is VYNE Therapeutics quarterly long term assets?
The current quarterly non current assets of VYNE is $2.66 M
What is the all time high quarterly non current assets for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly long term assets is $62.09 M
What is VYNE Therapeutics quarterly non current assets year-on-year change?
Over the past year, VYNE quarterly long term assets has changed by -$209.00 K (-7.28%)